POET Technologies

POET Technologies reported after the virtual annual general meeting the re-election of six board members and the appointment of Davidson & Company LLP as auditor. The board approved 79,450 restricted stock units for five independent directors. The company plans a production ramp-up and delivery of optical engines in mass production starting in the second half of 2026 and aims to expand capacity to up to 1 million units per month by the end of 2027. POET reported equity raises of $830 million in the past 12 months (plus potentially $661 million from warrants), plans about $50 million in Capex in H2 2026 and intends to increase staff by roughly 50 employees; despite 608% revenue growth over the last 12 months, analysts expect no profitability for this year. » Więcej na de.investing.com

POET Technologies' stock is showing extreme volatility: after strong gains it recently pulled back. The company has signed a development and supply agreement with Lumilens that includes an initial order of USD 50 million and a potential total volume of more than USD 500 million. At the same time POET completed a capital raise involving around 19.05 million common shares and accompanying warrants for gross proceeds of about USD 400 million, triggering dilution fears and high volatility. Investors should watch the use of proceeds and the commercial progress of the Lumilens collaboration; the stock remains speculative. » Więcej na finanzen.net

The POET Technologies share has seen strong swings after a sharp drop and subsequent recovery. The company closed a development and supply agreement with Lumilens for an electrical-optical interposer; Lumilens placed an initial order worth $50 million, with potential volume of more than $500 million over five years. At the same time, POET placed around 19.05 million common shares including warrants in a direct offering, raising gross proceeds of about $400 million (issue price $21.00 per unit); warrants with an exercise price of $26.25 were also issued. The proceeds are to be used to expand manufacturing, R&D, scale optical modules and for possible acquisitions, leaving dilution risks and high volatility in place. » Więcej na finanzen.net

Poet Technologies surged about 45.8% after announcing a contract with Lumilens that includes an initial optical hardware order of roughly $50 million and the potential for more than $500 million in future purchases. The deal also grants Lumilens warrants to buy about 22.9 million shares and immediate rights to roughly 2.3 million shares at $8.25 per share for nine years. Poet reported Q1 revenue of about $0.5 million and a loss of $0.08 per share, and separately agreed to raise about $400 million through a share-and-warrant offering, a move that could dilute shareholders. » Więcej na finance.yahoo.com

POET Technologies shares fell sharply after a short-seller report called the company’s partnerships and commercialization claims overstated and highlighted existing PFIC lawsuits and alleged lost orders. Q1 GAAP EPS of -$0.08 missed expectations, revenue rose to $0.5 million, and the company announced the issuance of 19,047,620 common shares plus a warrant (up to 22.9 million shares) in a direct offering, stoking dilution fears. There were also leadership changes (new COO, CFO retirement) and profit-taking after a prior rally, while the backdrop for speculative tech stocks remained weak. » Więcej na de.investing.com